Argenica Therapeutics' Phase 2 stroke drug trial hits major milestone

By Proactive Investors / November 06, 2024 / www.youtube.com / Article Link

Argenica Therapeutics Ltd (ASX:AGN, OTC:OTCMKTS: AGNTF) CEO and managing director, Dr Liz Dallimore talked with ...

Recent News

Geopolitical risk outlook unclear after US election

January 06, 2025 / www.canadianminingreport.com

Low valuations offer a cushion to mining sector

January 06, 2025 / www.canadianminingreport.com

Polarized gold and iron ore moves, moderate aluminum and copper gains

December 30, 2024 / www.canadianminingreport.com

Large TSXV stocks strong on company specific drivers

December 30, 2024 / www.canadianminingreport.com

Canadian political turmoil with Trump trade policy the catalyst

December 23, 2024 / www.canadianminingreport.com

See all >